FarmerP

@DrMakaryFDA Maybe if Anktiva caused a bloody, open sore like skin rash in NINETY PERCENT of patients it could be expanded to at least all NMIBC patients quickly...it has no side effects beyond what BCG alone has. It also may extend your life meaningfully so...FDA blocks it. 🖕🖕

TWO DAYS after receiving the application, FDA greenlit the new pancreatic cancer drug daraxonrasib for expanded access. This drug has also been granted a national priority voucher, which means a full application could be reviewed in a matter of weeks instead of 10-12 months.

@DrMakaryFDA Its pretty remarkable, then, that Anktiva is still only available for a small subset of bladder cancer patients. Slow walking that one huh?

@DrMakaryFDA @US_FDA The Anktiva sBLA for papillary bladder cancer has been sitting idle in your FDA for two months of "real time". "Ai....the cloud....digital..." All fluff, no action, and only benefitting big pharma's r&d expenses. Shame on you.

A milestone day for clinical trial innovation. We’re announcing the first real-time clinical trials, where @US_FDA can see data signals and endpoints in real time. A quick explainer:

@US_FDA @DrMakaryFDA Cures? If a small biotech used that word you'd come after them pretty hard...as you have with @ImmunityBio Maybe you need a warning letter? You gave them one for a commercial that was never publicly released because you BLOCK cures. Stop blocking Anktiva.

At 1:30pm today, FDA Commissioner @DrMakaryFDA will unveil FDA's real-time clinical trials initiative—a major step to accelerate cures for patients. Join us! youtube.com/live/hPT6X4SKO…

@DrMakaryFDA What a joke. You're hunting for higher profits for big pharma. You're delaying Anktiva and letting people die so you can go get your spot on a Big Pharma board and collect your pittance. Scum. Look less like a smug douche while gaslighting us, please.

The FDA is on the HUNT for promising therapies.

@MAHA_Action After following @ImmunityBio for years and years I can certainly see why any innovative, disruptive biotech would have incentive to go anywhere outside of the USA...anywhere less corrupt by big pharma lobbyists with a revolving door from FDA/BP boards.

“China is now eating our lunch.” RFK Jr. warns the U.S. is losing its edge to China in medical research and drug development. “They got more drugs approved last year.” “They went from running 3% of clinical trials to running 30%.” “We are losing scientists, we’re losing our IPs, we’re losing the best researchers.” “We’re going to lose our biosecurity.” “We are fast-tracking approvals now in our country at record levels.”

@Nina_Chase @ryangrim Source for that 30,000: Someone anonymous who supposedly told Bari Weiss 😂 So it's a fact!

@ryangrim They killed 30,000 people in January! I think her father would be just fine with getting them justice! So many people that wouldn’t push the button to save a city over one person! Sad to see such weakness!

It's amazing that Trump can trash Meghan McCain's dad for years but all it takes to win her over is a war on Iran. Truly her father's daughter. He'd be genuinely proud.

@DrPatrick @DrMakaryFDA @SecKennedy So is ALC still "just a number"? That's what FDA said not long ago. Sure seems like we're denying help to those who need it in order to defend big pharma's profits...something you both have seen and promised to change. Waiting...

Here we go with the drumbeat of evidence of how lymphopenia results in poorer prognosis in breast cancer, regardless of type and regardless of stage by Dr. Aditya Bardia, a renowned UCLA breast cancer oncologist. #1 Dec 2025: Early stage TRIPLE NEGATIVE BREAST CANCER at San Antonio Breast Cancer Symposium (SABCS): A study demonstrating that lymphopenia is associated with statistically LOWER pathological complete response (pCR) rates in patients with early-stage triple negative breast cancer (TNBC) treated with neoadjuvant chemo-immunotherapy. News tomorrow at @AACR on Stage 1, 2, and 3 breast cancer. aacrjournals.org/clincancerres/…

@DrMakaryFDA Yes, the serving of big pharma has never been more evident. You really have taken the regulatory capture landscape to a new gear. I hope the money is worth your soul. You'll be on the board of Eli Lilly in a few years if I'm right. The worst kind of human.

The FDA has shifted into a higher gear.

@DrPatrick @seanspicershow Be careful what you say 😂 don't want to get slapped on the wrist by the FDA again 🙄 @DrMakaryFDA I can't wait to hear about how every other place on Earth isn't stonewalling Anktiva to protect corporate interests and status quo like your FDA does. Shame!

Will be on @seanspicershow today to speak about our clinical trial programs, our science and the status of our global expansion. Great and exciting trip in Europe this week - they are amazingly advanced in immune cell therapy development.

@DrMakaryFDA Anktiva, now.

Thank you FDA scientists, innovators, inspectors, support staff and others for helping drive a year of reform and modernization.

@DrMakaryFDA Expand Anktiva now. The papillary decision from FDA is late. You're probably busy favoring big pharma, delaying their competition, and trying to cover up COVID crimes/injuries. You're the worst kind of human.

We’re lowering drug prices and getting decisions out efficiently.

@BillClinton Huh, I guess smoking cigars you pulled out of a 22 year old intern's vagina just doesn't do it for you anymore.

Once again, the best college hoops teams prove there's nothing like March Madness to get our jaws dropping, our hearts racing, and our brackets busting. Congratulations to the Bruins and the Wolverines!

@BetweenThieves7 @DrPatrick They're already on it!

@DrPatrick PLEASE PLEASE PLEASE. I beg you. On behalf of millions of hopeless sufferers, do a trial for Long Covid. Please. I could get a hundred thousand signatures for it. Easiest enrollment ever. @DrPatrick

The more we learn about the power of IL-15 and the literature that exists decades ago (since 2010!) and never exploited is so exciting. Sepsis is responsible for over 200,000 deaths annually in the United States. We are planning a trial in community acquired pneumonia and sepsis. What is remarkable is the finding that Pseudomonas, a bacterial infection induces apoptosis (cell death) of NK cells, dendritic cells and CD8+ T cells contributing to mortality. More remarkable is the finding that IL-15 blocks this killing of these protective NK and CD8 T cells and improves survival. In this paper the final conclusion: "IL-15 prevents two immunopathologic hallmarks of sepsis, namely, apoptosis and immunosuppression, and improves survival in two different models of sepsis. IL-15 represents a potentially novel therapy of this highly lethal disorder." The more we learn, the more wondrous is this IL-15 cytokine molecule in our body! Our Sepsis Trial: ResQ218B-CAP clinicaltrials.gov/study/NCT07492… pubmed.ncbi.nlm.nih.gov/20026737/

@IAmIronManSon @wafflesnspace @DrPatrick Our government can't even recommended vitamin D supplementation during a pandemic.I think his thinking is correct. Yes, no BP product to disrupt, but heavens forbid they promote an overall immune booster/disease killer. They'd like to treat more sick people.

@wafflesnspace @DrPatrick No, no real BP presence to upset the balance. Off you’re conspiratorial in your thinking. Should be smooth sailing, it’s a real drain on the system without a lot of monetary benefit. It’s likely to land in the SoC category, what could boosting one’s immune system hurt?

@DrMakaryFDA Great. Another win for big pharma (Eli lilly this time) and just what we need - more GLP-1 poisons for people "suffering from obesity".Are you serious? Anktiva, please.Any small biotech please. Anything more necessary and urgent than a pill for poor diet. 🤡

The new FDA is delivering more efficient drug reviews for the American people.

@Lancepantsalot @DrPatrick Yes, definitely would love to hear how our Saudi partners are doing with their launch. Keep up the great work!

@DrPatrick @DrPatrick we need an update on Saudi!

Capital in place.Approvals in 34 countries. Indication expansion globally in motion. Pipeline of combination trials cooking. Immunotherapy 2.0. Never give up.

@DrPatrick Looking forward to the morning.

Strengthening the balance sheet. Recharging for global expansion. Stay tuned.

@DrMakaryFDA @AHIPCoverage Read the room: you're a big pharma profit/status quo protector until you prove otherwise. Nobody cares if you fast track high dose glps or big pharma poison chemo drugs. Anktiva, now. You are to medicine what Kash Patel is to Epstein.

Thank you, @AHIPCoverage! Enjoyed discussing FDA’s role in cutting red tape and bringing more affordability to healthcare.

@DrPatrick Tip:Just say your product is "safe & effective" and sponsor every media outlet to repeat.Then try to hide your side fx for 80 years. Hell, don't even have any long term safety data or efficacy.Then make sure your product causes turbo cancers. FDA won't mind that 🤡 @DrMakaryFDA

This is how we build the 'World Bank of NK Cells' and make Immunotherapy 2.0 accessible to all of humanity. Our M-ceNK Phase 2 clinical trials ongoing with process development from over 60 healthy volunteers and patients with cancer completed to date. The future of growing natural killer (NK) cells to fight cancer and protect our immune systems is being assembled right now (NANT Leonardo), the first AI machine driven, cell therapy robotic manufacturing system landing soon!